Switzerland vs Andorra vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 96% | 98% |
| 2023 | 95% | 99% |
| 2022 | 96% | 98% |
| 2021 | 95% | 99% |
| 2020 | 97% | 98% |
| 2019 | 95% | 99% |
| 2018 | 95% | 99% |
| 2017 | 95% | 99% |
| 2016 | 94% | 97% |
| 2015 | 94% | 96% |
| 2014 | 94% | 96% |
| 2013 | 93% | 95% |
| 2012 | 93% | 98% |
| 2011 | 93% | 99% |
| 2010 | 92% | 99% |
| 2009 | 92% | 98% |
| 2008 | 92% | 98% |
| 2007 | 87% | 94% |
| 2006 | 87% | 91% |
| 2005 | 87% | 94% |
| 2004 | 82% | 98% |
| 2003 | 82% | 96% |
| 2002 | 82% | 98% |
| 2001 | 82% | 97% |
| 2000 | 82% | 97% |
| 1999 | 82% | 97% |
| 1998 | 81% | 90% |
| 1997 | 83% | 90% |
| 1996 | 83% | - |
| 1995 | 83% | - |
| 1994 | 83% | - |
| 1993 | 83% | - |
| 1992 | 83% | - |
| 1991 | 83% | - |
| 1990 | 90% | - |
| 1989 | 90% | - |
| 1988 | 70% | - |
| 1987 | 70% | - |
| 1986 | 70% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 96% | 98% |
| 2023 | 95% | 98% |
| 2022 | 96% | 98% |
| 2021 | 96% | 99% |
| 2020 | 97% | 99% |
| 2019 | 96% | 99% |
| 2018 | 96% | 99% |
| 2017 | 96% | 99% |
| 2016 | 96% | 98% |
| 2015 | 96% | 97% |
| 2014 | 96% | 97% |
| 2013 | 96% | 96% |
| 2012 | 96% | 99% |
| 2011 | 96% | 99% |
| 2010 | 95% | 99% |
| 2009 | 95% | 99% |
| 2008 | 95% | 99% |
| 2007 | 94% | 96% |
| 2006 | 94% | 93% |
| 2005 | 94% | 98% |
| 2004 | 93% | 99% |
| 2003 | 93% | 99% |
| 2002 | 93% | 97% |
| 2001 | 93% | 96% |
| 2000 | 93% | 98% |
| 1999 | 93% | 90% |
| 1998 | 88% | 89% |
| 1997 | 89% | 90% |
| 1996 | 89% | - |
| 1995 | 89% | - |
| 1994 | 89% | - |
| 1993 | 89% | - |
| 1992 | 89% | - |
| 1991 | 89% | - |
| 1990 | 90% | - |
| 1989 | 90% | - |
| 1988 | 90% | - |
| 1987 | 90% | - |
| 1986 | 90% | - |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 86% | 97% |
| 2023 | 80% | 97% |
| 2022 | 76% | 96% |
| 2021 | 73% | 98% |
| 2020 | 72% | 98% |
| 2019 | 69% | 98% |
| 2018 | 69% | 98% |
| 2017 | 69% | 98% |
| 2016 | - | 94% |
| 2015 | - | 94% |
| 2014 | - | 95% |
| 2013 | - | 94% |
| 2012 | - | 97% |
| 2011 | - | 99% |
| 2010 | - | 96% |
| 2009 | - | 96% |
| 2008 | - | 97% |
| 2007 | - | 91% |
| 2006 | - | 84% |
| 2005 | - | 79% |
| 2004 | - | 77% |
| 2003 | - | 81% |
| 2002 | - | 84% |
| 2001 | - | 84% |
| 2000 | - | 84% |
| 1999 | - | 75% |
| 1998 | - | 80% |
| 1997 | - | 75% |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
| 1991 | - | - |
| 1990 | - | - |
| 1989 | - | - |
| 1988 | - | - |
| 1987 | - | - |
| 1986 | - | - |
The first measles dose reaches 96% of children aged 12–23 months in Switzerland and 98% in Andorra: 2 percentage points more in Andorra. The third DTP dose reaches 96% in Switzerland and 98% in Andorra, 2 points more in Andorra. The third hepatitis B dose reaches 86% in Switzerland and 97% in Andorra, 11 points more in Andorra. In 1997, the first measles dose reached 83% in Switzerland and 90% in Andorra, 7 percentage points more in Andorra.
Switzerland vs Andorra: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 96% (2024) | 98% (2024) |
| DTP3 | 96% (2024) | 98% (2024) |
| HepB3 | 86% (2024) | 97% (2024) |
Switzerland and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Andorra and nearby countries: measles vaccination (MCV1), % of children aged 12–23 months
Of Switzerland and its four neighbors, the latest coverage of the first measles dose is highest in Switzerland, at 96%, and lowest in Austria, at 90%; of Andorra and the five nearby countries, the latest coverage of the first measles dose is highest in Luxembourg, at 99%, and lowest in Monaco, at 88%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1986–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.